Year Item Type Full Text

2019

Using registry data to estimate the effects of long-term treatment use in cystic fibrosis. (2019) Newsome, S

2018

Defining the relationship between the extent of mid-wall late gadolinium enhancement and adverse heart failure events in patients with dilated cardiomyopathy. (2018) Halliday, B; Baksi, A; Gulati, A; Ali, A; Newsome, S; Arzanauskaite, M; Izgi, C; Lota, A; Tayal, U; Vassiliou, V; Cook, S; Cleland, J; Pennell, D; Prasad, S

Sex differences in the natural history and outcome of dilated cardiomyopathy. (2018) Halliday, B; Gulati, A; Ali, A; Newsome, S; Lota, A; Tayal, U; Vassiliou, V; Arzanauskaite, M; Izgi, C; Cook, S; Pennell, D; Collins, P; Cleland, J; Prasad, S

Prognostic significance of non-ischaemic myocardial fibrosis in patients with normal LV size and function: A large CMR registry study. (2018) Lota, A; Tsao, A; Al-Balah, A; Patel, A; Newsome, S; Mouy, F; Halliday, B; Cleland, J; Ware, J; Cook, S; Pennell, D; Prasad, S

2017

Incremental prognostic value of cardiopulmonary exercise testing in non-ischemic dilated cardiomyopathy. (2017) Halliday, B; Chiew, K; Newsome, S; Wassall, R; Lota, A; Tayal, U; Jackson, R; Rahneva, T; Baksi, A; Cleland, J; Prasad, S

Sudden cardiac death risk stratification in patients with mild dilated cardiomyopathy. (2017) Halliday, BP; Gulati, A; Ali, A; Guha, K; Newsome, S; Arzanausikaite, M; Vassiliou, VS; Lota, A; Tayal, U; Khalique, Z; Izgi, C; Alpendurada, F; Cleland, JG; Pennell, DJ; Prasad, SK

Prognostic value of cardiovascular magnetic resonance in the prediction of atrial fibrillation in hypertrophic cardiomyopathy. (2017) Liew, A; Raphael, C; Mitchell, F; Kanaganayagam, G; di Pietro, E; Newsome, S; Cooper, R; Gatehouse, P; Vassiliou, V; Pennell, D; Frenneaux, M; O'Hanlon, R; Prasad, S

127 Relationship between plasma concentrations of b-type natriuretic peptide and exercise capacity in hypertrophic cardiomyopathy. (2017) Lota, A; Mouy, F; Wassall, R; Newsome, S; Halliday, B; Baksi, J; Pantazis, A; Ware, J; Cook, S; Pennell, D; Cleland, J; Prasad, S

Relationship between plasma concentrations of b-type natriuretic peptide and exercise capacity in hypertrophic cardiomyopathy. (2017) Lota, A; Mouy, F; Wassall, R; Newsome, S; Halliday, B; Baksi, J; Ware, J; Pantazis, A; Pennell, D; Cleland, J; Prasad, S; Cook, S

Harnessing registry data to estimate treatment effects: investigating the effects of dornase alfa on lung function and IV Days. (2017) Newsome, S; Keogh, R; Daniel, R

Performance of methods for handling time-dependent confounding under real-world uncertainty. (2017) Newsome, S; Keogh, R; Daniel, R

Harnessing the UK registry data: how does long-term dornase alfa (DNase) use affect lung function? (2017) Newsome, SJ; Keogh, R; Daniel, RM

Risk factors for the development of heart failure in hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study. (2017) Raphael, C; Mitchell, F; Kanaganayagam, G; Liew, A; di Pietro, E; Vieira, M; Newsome, S; Vassiliou, V; Ali, A; Wong, B; Sun, K; O'Hanlon, R; Pennell, D; Prasad, S

Evaluation of titin cardiomyopathy in patients with dilated cardiomyopathy reveals a blunted hypertrophic response, an early arrhythmic risk and a significant interaction with alcohol. (2017) Tayal, U; Buchan, R; Whiffin, N; Newsome, S; Walsh, R; Barton, P; Ware, J; Cook, S; Prasad, S

Integrated Analysis of the Clinical Manifestations and Phenotypic Drivers of Titin Cardiomyopathy. (2017) Tayal, U; Buchan, R; Whiffin, N; Newsome, S; Walsh, R; Barton, P; Ware, J; Prasad, S; Sa, C

Multimodality assessment of risk in dilated cardiomyopathy- the importance of CMR. (2017) Tayal, U; Newsome, S; Voges, I; Whiffin, N; Buchan, R; Halliday, B; Lota, A; Izgi, C; Barton, P; Baruah, R; Jarman, J; Frenneaux, M; Pennell, D; Ware, J; Cook, S; Prasad, S

Defining the genetic architecture of dilated cardiomyopathy insights from population genetic variation and the role of titin. (2017) Tayal, U; Newsome, S; Walsh, R; Voges, I; Whiffin, N; Buchan, R; Halliday, B; Lota, A; Barton, P; Baruah, R; Jarman, J; Frenneaux, M; Ware, J; Cook, S; Prasad, S

Precise phenotyping with CMR identifies moderate alcohol consumption as an important phenotypic modifier of titin cardiomyopathy. (2017) Tayal, U; Newsome, S; Whiffin, N; Buchan, R; Walsh, R; Barton, P; Ware, J; Cook, S; Prasad, S

2016

Euroscore II and STS Risk Model Scores in Aortic Stenosis: Can We Rely on Them? (2016) Aggarwal, N; Selvendran, S; Newsome, S; Malley, T; Auger, D; Prasad, S; Vassiliou, V

Gender differences in the natural history and outcome of dilated cardiomyopathy. (2016) Halliday, B; Ali, A; Gulati, A; Newsome, S; Tayal, U; Lota, A; Vassiliou, V; Arzanauskaite, M; Cook, S; Pennell, D; Prasad, S

The natural history of non-ischaemic dilated cardiomyopathy diagnosed after the age of 65 years of age. (2016) Halliday, B; Ali, A; Gulati, A; Newsome, S; Tayal, U; Wage, R; Arzanauskaite, M; Assomull, R; Shakespeare, C; Pakrashi, T; Collinson, J; Cook, S; Pennell, D; Prasad, S

Risk stratification of mild-to-moderate phenotypes of dilated cardiomyopathy – the role of mid-wall fibrosis. (2016) Halliday, B; Gulati, A; Ali, A; Guha, K; Arzanauskaite, M; Newsome, S; Lota, A; Tayal, U; Vassiliou, V; Auger, D; Khalique, Z; Pareek, N; Pennell, D; Cook, S; Prasad, S

Investigating Treatment Effects using the UK CF Registry: Do treatments affect health in ways not previously identified through trials? (2016) Newsome, S; Keogh, R.D., Rhian

Predictors of 2-year mortality following hospital discharge in patients with acute coronary syndromes: a new risk score from the EPICOR and EPICOR Asia studies. (2016) Pocock, SJ; Huo, Y; van de Werf, F; Newsome, S; Chin, CT; Vega, AM; Medina, J; Bueno, H

Effects Of Truncating Variants In Titin On Cardiac Phenotype and Left Ventricular Remodelling In Dilated Cardiomyopathy. (2016) Tayal, U; Buchan, R; Whiffin, N; Newsome, S; Mazzarotto, F; Walsh, R; Ware, J; Prasad, S; Cook, S

Comprehensive assessment of genotype phenotype correlations in dilated cardiomyopathy due to sarcomeric gene mutation. (2016) Tayal, U; Buchan, R; Whiffin, N; Newsome, S; Mazzarotto, F; Walsh, R; Ware, J; Prasad, S; Cook, S

Clinical and Genetic Characteristics of Familial Dilated Cardiomyopathy in a Large UK Prospective Cohort. (2016) Tayal, U; Buchan, Rachel, J; Whiffin, N; Newsome, S; Mazzarotto, F; Walsh, R; Ware, James, S; Cook, S; Prasad, S

The presence of a truncating mutation in titin independently associates with arrhythmic burden in patients with dilated cardiomyopathy. (2016) Tayal, U; Newsome, S; Buchan, R; Whiffin, N; Shakespeare, C; Ware, J; Cook, S; Prasad, S

Genetic determinants of arrhythmia in dilated cardiomyopathy. (2016) Tayal, U; Newsome, S; Buchan, R; Whiffin, N; Walsh, R; Ware, J; Cook, S; Prasad, S

Defining titin cardiomyopathy: genotype-phenotype correlations in a large prospective cohort of dilated cardiomyopathy patients. (2016) Tayal, U; Newsome, S; Buchan, R; Whiffin, N; Walsh, R; Ware, J; Prasad, S; Cook, S

Evaluating the Significance of Left Ventricular Midwall Fibrosis Detected by Late Gadolinium Enhancement Imaging on Left Ventricular Functional Remodelling in Dilated Cardiomyopathy. (2016) Tayal, U; Newsome, S; Wage, R; Ali, A; Halliday, B; Farzad, Z; Pennell, DJ; Cook, S; Prasad, S

Evaluation of CMR predictors of Right Ventricular Remodelling in Dilated Cardiomyopathy. (2016) Tayal, U; Newsome, S; Wage, R; Ali, A; Halliday, B; Farzad, Z; Pennell, DJ; Cook, S; Prasad, S

A simple clinical model to predict presence of myocardial fibrosis in patients with aortic stenosis. (2016) Vassiliou, V; Malley, T; Newsome, S; Chin, CW; Dweck, MR; Pennell, DJ; Prasad, S